COVID-19: US CDC to weigh rare clot risk with J&J vaccine as use paused
J&J's single-dose shot is less widely used in the United States compared to the 185 million doses delivered of Moderna and Pfizer/BioNTech's two-shot vaccines.
Full Article
COVID-19: US CDC to weigh rare clot risk with J&J vaccine as use paused
Jerusalem Post
0 shares
1 views
You might like
Related news coverage
Indonesia on alert to avert India-like viral wave
MENAFN.com
(MENAFN - Asia Times) JAKARTA � India's second-wave Covid-19 disaster appears to have reinforced the Indonesian government's..
-
Continuing to use Johnson & Johnson's vaccine could save 1,400 lives in the next 6 months, the CDC says
Business Insider
-
California man hospitalized with clot after J&J vaccination
SeattlePI.com
-
Plant-based "vaccine" uses herbs to activate the immune system against the coronavirus, without the blood clot risk
NaturalNews.com
-
With OK from experts, some states resume use of J&J vaccine
SeattlePI.com
Advertisement
More coverage
Ontario man speaks out after father has severe stroke from rare blood clot following AstraZeneca vaccine
CBC.ca
An Ontario man whose father suffered a severe stroke from a rare blood clot after receiving the AstraZeneca-Oxford COVID-19 vaccine..